France: Affluent Medical raises €25m from IPO on Euronext Paris

Affluent Medical, a French company specialising in the development and production of mini-invasive prostheses used for treating heart disease and urinary incontinence, has raised €25m (US$30.3m) from an IPO on Euronext Paris of approximately 18.2 million shares, 2.9 million of which were new shares. Each share was priced at €8.60. The capital raising exercise provides…

You must be a HMI Subscriber to view this content.

Subscribe Now »